Chemical | Mechanism of action | Clinical findings | Decontamination* | Management¶ |
Nerve agents:
| Anticholinesterase:
| Cholinergic crisisΔ with either:
|
| Do not delay antidotal therapy if nerve agent exposure is suspected◊:
For specific dosing and indications, refer to UpToDate topics on chemical terrorism. |
Cyanide (AC) | Cytochrome oxidase inhibition:
|
|
| Do not delay antidotal therapy if cyanide poisoning is suspected◊:
For specific dosing and indications, refer to UpToDate topics on cyanide poisoning and chemical terrorism. |
Pulmonary, type I (central, eg, hydrogen chloride, hydrogen fluoride) or combination agents (eg, chlorine) | Type I:
Combination:
| Type I:
Combination:
|
|
|
Type II pulmonary agents (eg, phosgene [GG]) or combination agents (eg, chlorine) | Type II:
Combination:
| Delayed onset chest tightness and shortness of breath Combination, rapid onset of:
|
|
|
Crowd-control agents:
| Alkylation Release of substance P (OC) |
|
|
|
Mustard compounds (eg, sulfur mustard [H]) | Alkylation |
|
| Symptomatic and supportive care for partial thickness burns, corneal toxicity, and bone marrow suppression |
Lewisite (L) |
|
|
| |
BZ (3-quinuclidinyl benzilate) | Competitive antagonism of acetylcholine at muscarinic receptors | Anticholinergic effects:
| Irrigate skin with water or soapy water |
For specific indications and dosing, refer to UpToDate topics on chemical terrorism and anticholinergic poisoning. |
CNS: central nervous system; CPAP: continuous positive airway pressure; ICU: intensive care unit.
* Decontamination, especially for patients with significant nerve agent or vesicant exposure, should be performed by health care providers wearing adequate personal protective equipment. For first receiving facilities (eg, hospital emergency departments), this consists of nonencapsulated, chemically-resistant body suit, boots, and gloves with a full-face air purifier mask/hood. Refer to UpToDate topics on chemical weapons for more information regarding the proper performance of decontamination of chemically exposed patients.
¶ Emergent supportive of chemical exposures should always include the ABCDDs: Airway, Breathing, Circulation, immediate Decontamination (meaning immediate local, or spot decontamination of any suspicious liquid on the skin or in wounds), and Drugs (including specific antidotes).
Δ Signs of cholinergic crisis include miosis, bronchorrhea with wheezing, copious salivation, lacrimation, diaphoresis, vomiting, and diarrhea.
◊ Intraosseous route is likely equivalent to intravenous for administration of antidotes. Refer to UpToDate topics on intraosseous infusion.
§ Inhaled ipratropium bromide (500 mcg inhaled, may repeat once) may complement parenteral atropine administration for the treatment of bronchospasm.
¥ Administration of scopolamine may help preserve atropine in the setting of large numbers of patients with severe nerve gas exposure. For scopolamine dosing refer to UpToDate topics on chemical terrorism.
‡ High flow nasal cannula and noninvasive positive pressure ventilation should be avoided in patients with upper airway obstruction after combination agent (eg, chlorine) exposure.